
An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization. . . . → Read More: AI Image Analysis Shown to Predict Embryo Health
|
|||||
![]() An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization. . . . → Read More: AI Image Analysis Shown to Predict Embryo Health ![]() A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease. . . . → Read More: Biotech in $1.5B Gene-Editing Tech License Deal ![]() A study of people with and without Alzheimer’s disease found differences between women and men in their state of cognitive decline with data from mobile devices. . . . → Read More: Digital Biomarkers Reveal Alzheimer’s Gender Differences ![]() Two companies are developing a system to identify optimal times for people with Parkinson’s disease to take their symptom-reducing medications. . . . → Read More: Companies Partner on Optimal Parkinson’s Drug Delivery ![]() A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device ![]() The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes ![]() Researchers in Europe and the U.S. are investigating gut processes in pigs to reduce antibiotics commonly used against infections, a source of antibiotic resistance. . . . → Read More: Intl. Team Studying Antibiotic Overuse in Pigs ![]() Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health. . . . → Read More: Hydrogel Shown to Boost Beneficial Gut Microbes ![]() Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership. . . . → Read More: Ginkgo Acquires Bayer Agricultural Biologics Technology ![]() A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers. . . . → Read More: Trial Begins Testing Crispr Gut Microbiome Therapy |
|||||
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |